The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases

J Optom. 2022;15 Suppl 1(Suppl 1):S50-S57. doi: 10.1016/j.optom.2022.08.001. Epub 2022 Oct 8.

Abstract

In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is attracting increasing global interest in the field of ophthalmology. DL models are considered the current state-of-art among the AI technologies. In fact, DL systems have the capability to recognize, quantify and describe pathological clinical features. Their role is currently being investigated for the early diagnosis and management of several retinal diseases and glaucoma. The application of DL models to fundus photographs, visual fields and optical coherence tomography (OCT) imaging has provided promising results in the early detection of diabetic retinopathy (DR), wet age-related macular degeneration (w-AMD), retinopathy of prematurity (ROP) and glaucoma. In this review we analyze the current evidence of AI applied to these ocular diseases, as well as discuss the possible future developments and potential clinical implications, without neglecting the present limitations and challenges in order to adopt AI and DL models as powerful tools in the everyday routine clinical practice.

Keywords: Artificial intelligence; Deep learning; Glaucoma; Machine learning; Macula; Medical retina; Optical coherence tomography; Telemedicine.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence
  • Diagnostic Techniques, Ophthalmological
  • Glaucoma* / diagnosis
  • Humans
  • Infant, Newborn
  • Ophthalmology*
  • Retina